Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes  by Muno, Daisaku et al.
Generation of both MHC class I- and class II-restricted antigenic
peptides from exogenously added ovalbumin in murine phagosomes
Daisaku Munoa, Eiki Kominamia, Toshiaki Mizuochib;*
aDepartment of Biochemistry, School of Medicine Juntendo University, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan
bDepartment of Bacterial and Blood Products, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
Received 16 June 2000; accepted 6 July 2000
Edited by Marco Baggiolini
Abstract The phagosome fraction derived from a murine
macrophage cell line (J774.1), which had internalized ovalbumin
(OVA)-coated latex beads, was isolated. The peptides recovered
from the phagosome fraction were separated on reverse phase
HPLC and each fraction was analyzed for the content of either
major histocompatibility complex (MHC) class I- or class II-
restricted OVA-derived peptide. Both peptides were detected in
the phagosome fraction after less than 15 min of internalization.
It was also indicated that phagosomes degrade OVA protein into
both MHC class I- and class II-restricted antigenic peptides by
employing the same types of cathepsins. Furthermore, the results
suggest that the MHC class I-restricted peptide rapidly exits
from the phagosome to the cytosol. These findings illustrate a
potential role for phagosomes not only in MHC class II-
restricted but also in MHC class I-restricted exogenous antigen
presentation pathways. Our results also point to the vital role of
phagosomes in non-cytosolic antigen presentation pathway, in
which further degradation of antigens by the proteasome is
dispensable. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In the initial step of immune responses, antigen processing
and presentation by antigen presenting cells (APCs) are cru-
cial. In general, this step has been classi¢ed into two distinct
pathways [1^3]. Exogenous antigens are processed through the
major histocompatibility complex (MHC) class II-restricted
pathway, in which antigens are internalized by APC and de-
graded by proteases in their acidic vesicular compartments,
such as the endosome and the lysosome. The generated pep-
tides are loaded onto MHC class II molecules under the in-
£uence of MHC DM and DO molecules [4], and are then
transported to the cell surface for recognition by CD4 T
cells. On the other hand, endogenous antigens are processed
through the MHC class I-restricted pathway, in which cyto-
plasmic proteins are degraded by the proteasome and the
resulting peptides which are generated are transported into
the endoplasmic reticulum (ER) by a membrane-associated
peptide transporter (TAP), and assembled into complexes
with nascent MHC class I molecules. The peptide^MHC class
I complexes are then transported to the cell surface for rec-
ognition by CD8 T cells. Recent ¢ndings, however, have
challenged the above strict segregation of MHC class I and
class II peptide loading pathways [5,6]. One of the most in-
triguing exceptions is the fact that exogenous particulate anti-
gens, including microbes, are internalized and processed by
phagocytes, and the resulting antigenic peptides which are
generated are presented by means of MHC class I molecules
to CD8 T cells [7^11]. Although this novel pathway may
play an important role in the immune surveillance of a host,
little is known relative to where and how antigenic peptides
are generated and encountered MHC class I molecules. The
results of early studies suggested that antigens may be trans-
ferred from vacuolar compartments (e.g. phagolysosomes) to
the cytosol, thereby following the conventional MHC class I
pathway which is highly dependent on both the proteasome
and TAP [10]. In contrast, other studies have concluded that
there exists a non-cytosolic pathway for the presentation of
exogenous antigens by MHC class I molecules. For example,
the presentation of bacteria-associated or bead-bound ovalbu-
min (OVA) is not a¡ected by the presence of brefeldin A, an
inhibitor of protein exocytosis from the ER [7,9]. In another
study, the MHC class I presentation of viral antigen was
found to be una¡ected by a TAP mutation [12]. In both path-
ways, internalized exogenous antigens are presumably de-
graded ¢rst in vacuolar compartments, and then loaded
onto MHC class I molecules. In the cytosolic pathway, anti-
genic proteins are not necessarily degraded into small pep-
tides, which are ready to bind to MHC class I molecules in
phagosomes, since the proteasome resides in the cytosol for
further degradation. However, in the non-cytosolic pathway,
it is an advantage for the APC to generate ‘ready to bind’
peptides in the phagosome, regardless of where they bind to
MHC class I molecules.
The present study describes an attempt to determine
whether a phagosome is capable of degrading a protein anti-
gen (OVA) into small peptides which are able to bind to either
MHC class I or class II molecules without the need for further
degradation. Our results show that both types of peptides can
be simultaneously generated in the phagosome and the same
types of cathepsins are involved in the digestion of both types
of peptides. Furthermore, it was found that the generated
MHC class I-restricted antigenic peptides rapidly exit the
phagosome to the cytosol. The role of phagosomes in the
immune surveillance for exogenous pathogens is discussed
from the viewpoint of possible applications for the develop-
ment of vaccines.
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2. Materials and methods
2.1. Mice and cells
Female BALB/c mice and C57BL/10 mice were purchased from
Japan SLC Inc. (Shizuoka, Japan). A murine macrophage cell line,
J774.1 was maintained in RPMI 1640 containing 10% heat-inactivated
fetal calf serum, 1% glutamine, 100 U/ml penicillin and 100 Wg/ml
streptomycin at 37‡C in an atmosphere of 5% CO2. An OVA323ÿ339-
speci¢c, I-Ad-restricted T cell clone (DOT.1) was established in our
laboratory from a strain of transgenic mice, which express T cell
receptors from the OVA-speci¢c DO11.10 T hybridoma [13] and
was generously provided by Dr. Shimizu (Tokyo Metropolitan Insti-
tute of Gerontology, Tokyo, Japan). An OVA257ÿ264 (SIINFEKL)-
speci¢c, H-2Kb-restricted T cell hybridoma (CD8OVA1.3) [7] was
generously provided by Dr. Harding (Case Western Reserve Univer-
sity, Cleveland, OH, USA). An IL-2-dependent T cell clone, CTLL-2,
was utilized for determining the amount of IL-2 produced by the
above mentioned T cell clone or the T cell hybridoma upon stimula-
tion.
2.2. Reagents
Latex beads (0.8 Wm, Sigma, St. Louis, MO, USA) were non-co-
valently conjugated with OVA by incubation with 3.2 mg/ml of OVA
(Sigma, St. Louis, MO, USA) in citrate bu¡er (pH 4.2) as described
by Ramachandra et al. [14]. E-64-d and CA-074, prepared by M.
Murata et al., were donated by Dr. Hanada, Taisho Pharmaceutical
Co. (Saitama, Japan). Pepstatin A was purchased from Sigma (St.
Louis, MO, USA). The gel ¢ltration column was obtained from Phar-
macia; the reverse phase high performance liquid chromatography
(HPLC) column (TSK-80TM) was from Tosoh (Tokyo, Japan).
2.3. Isolation of phagosome fraction
Phagosomes were isolated by £otation on sucrose gradients as de-
scribed by Desjardins et al. with minor modi¢cations. [15]. Phago-
somes were formed by the internalization of latex beads (10% suspen-
sion) diluted 1:200 in culture medium (4 ml/dish) at 37‡C for 15 min.
The cells were then washed with phosphate-bu¡ered saline (PBS)
(3U10 min) at 4‡C on a rocker, followed by a chase period (from
15 to 45 min) in medium without beads at 37‡C. All pulses and chases
were performed in an atmosphere of 5% CO2. After the internaliza-
tion of the latex beads, the cells were washed with cold PBS (three
timesU5 min) and scraped with a rubber policeman in PBS at 4‡C
and resuspended with 1 ml of homogenization bu¡er (250 mM su-
crose, 8 mM imidazole, pH 7.4). The cells were disrupted by multiple
passages through a tuberculin syringe with a 25 gauge needle. The
homogenates were then centrifuged at 1000Ug for 2 min to remove
nuclei and unbroken cells. The unbroken cells were resuspended in
homogenization bu¡er and the homogenization cycle was repeated
twice. Phagosomes and dense body organelles were pelleted from
the combined post-nuclear supernatant by centrifugation at
Fig. 1. Detection of OVA-derived MHC class I-restricted antigenic peptides (OVA257ÿ264 ; SIINFEKL) and MHC class II-restricted antigenic
peptides (OVA323ÿ339) in phagosomes. A murine macrophage cell line (J774.1) was cultured with OVA-coupled latex beads for 15 min. Phago-
some fractions were then isolated and the resulting peptides were recovered by sonication and centrifugation as described in Section 2. The pep-
tides fractions were then separated on reverse phase HPLC (A), and each peptide fraction was assayed for the content of either OVA257ÿ264
(SIINFEKL) (B) or OVA323ÿ339 (C) as described in Section 2. The results are representative of two independent experiments.
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40 000Ug for 15 min. The pellet was resuspended with 0.75 ml ho-
mogenization bu¡er and brought to 40% sucrose by adding the same
volume of a 62% sucrose solution. This 40% sucrose supernatant was
loaded onto the top of a 0.5 ml cushion of 62% sucrose, after which
1 ml of 35% sucrose, 1 ml of 25% sucrose and 1 ml of 10% sucrose
solutions were added. Centrifugation was done in a swinging bucket
rotor (Beckman SW55Ti rotor) at 100 000Ug for 1 h at 4‡C. The LBF
(latex bead fraction) band was collected from the interface of the 10
and 25% sucrose solutions and resuspended with 12 ml of cold PBS.
The LBF was ¢nally pelleted by centrifugation at 40 000Ug for 15
min at 4‡C. In some experiments, the remaining homogenates were
then centrifuged at 100 000Ug for 1 h, and the obtained supernatants
were used as cytosol fractions.
2.4. HPLC fractionation of peptides
After the addition of mixtures of protease inhibitors, which con-
sisted of phenyl-methylsulfonyl £uoride (1 mM), pepstatin A (10 Wg/
ml), leupeptin (10 Wg/ml) and E-64-d (10 Wg/ml), both phagosome and
cytosol fractions were sonicated and then centrifuged at 10 000Ug for
5 min to remove the latex beads. The supernatant was applied onto a
Superdex peptide gel ¢ltration column (0.7U30 cm) which had been
equilibrated with PBS. Fractions containing antigen peptides were
separated on a reverse phase HPLC column (TSK-80TM, Tisoh, To-
kyo). The peptides were eluted with a linear gradient of 0^40% ace-
tonitrile in 0.1% tri£uoroacetic acid.
2.5. Antigen presentation assay
HPLC fractions which contained peptides were lyophilized and
stored until use. These samples were reconstituted with 300 Wl of assay
culture medium (RPMI 1640 supplemented with 10% heat-inactivated
fetal calf serum, non-essential amino acids, glutamine, sodium pyru-
vate and antibiotics). For the detection of the OVA257ÿ264 (SIIN-
FEKL) in the peptide fractions, 5U104 CD8OVA1.3 cells (100 Wl)
were cultured in triplicate with 100 Wl of the reconstituted peptide
solution in a £at bottom 96 wells culture plate for 24 h at 37‡C in
an atmosphere of 5% CO2. For the detection of the OVA323ÿ339,
1U104 DOT.1 cells (100 Wl) were cultured in triplicate with 100 Wl
of the reconstituted peptide solution and irradiated (3000 R) BALB/c
spleen cells (5U104) in a round bottom 96 wells culture plate for 24 h
at 37‡C in an atmosphere of 5% CO2. Culture supernatants were
assayed for their IL-2 contents by the bioassay using CTLL-2 as
previously described [16].
3. Results
3.1. Detection of OVA-derived MHC class I- and class
II-restricted antigenic peptides in phagosome
Phagosomes were isolated from J774.1 cells which had in-
ternalized OVA-coated latex beads for 15 min. Fractions con-
taining antigen peptides were separated on a reverse phase
HPLC column (Fig. 1A). Each peptide fraction was analyzed
for the content of either the MHC class I-restricted peptide,
OVA257ÿ264 (SIINFEKL), or the MHC class II-restricted pep-
tide, OVA323ÿ339, by utilizing a SIINFEKL-speci¢c, H-2Kb-
restricted T cell hybridoma (CD8OVA1.3) or an OVA323ÿ339-
speci¢c, I-Ad-restricted T cell clone (DOT.1), respectively (see
Section 2). As shown in Fig. 1, the MHC class I-restricted
peptide (SIINFEKL) and the MHC class II-restricted peptide
(OVA323ÿ339) were found in fraction 7 (Fig. 1B) and fraction 3
(Fig. 1C), respectively. When the synthesized SIINFEKL and
OVA323ÿ339 peptides were applied to the same HPLC column,
they were eluted in fractions 7 and 3, respectively (data not
shown). We therefore conclude that, in the case of phago-
somes of J774.1, OVA was degraded into peptides which are
immediately ready to bind to the appropriate MHC mole-
cules, i.e. class I or class II. These results indicate that the
phagosome per se is capable of digesting antigenic protein
molecules into the ¢nal form of antigenic peptides. This fact
is important particularly when we consider the MHC class I-
restricted antigen presentation pathway, an issue which is dis-
cussed below.
3.2. E¡ect of protease inhibitors on the generation of
OVA-derived MHC class I- and class II-restricted
antigenic peptides in phagosome
We next attempted to determine what types of enzymes are
involved in the degradation of OVA antigen into the antigenic
peptides in the phagosomes. Various protease inhibitors, in-
cluding pepstatin A, E-64-d and CA-074, were added to the
culture of J774.1 during the phagocytosis of the OVA-coupled
latex beads. Peptides which were isolated from the phago-
somes were separated on HPLC and fractions corresponding
to SIINFEKL or OVA323ÿ339 were isolated. Each fraction was
assayed for peptide contents as described in Fig. 1. All of the
protease inhibitors used in the experiments were found to
substantially inhibit the generation of both MHC class I-
and class II-restricted antigenic peptides (Fig. 2). It is note-
worthy, in this respect, that CA-074, a speci¢c inhibitor of
cathepsin B [17], interferes with the generation of both anti-
genic peptides, indicating that cathepsin B is indeed involved
in the degradation of the OVA protein in the phagosome.
3.3. Transfer of the MHC class I-restricted peptide,
SIINFEKL, from phagosome to cytosol
It has recently been demonstrated that phagosomes consti-
tute fully competent antigen processing compartments for the
formation of peptide^class II MHC complexes [14]. It would
be of interest to determine the fate of the MHC class I-re-
stricted peptides, once they were generated in the phagosomes.
The question arises as to whether they form peptide^class I
MHC complexes in the phagosome. Are they transferred to
the cytosol instead as would be expected by the proposed
MHC class I-restricted antigen presenting pathway, in which
Fig. 2. E¡ect of protease inhibitors on the generation of OVA-de-
rived MHC class I- and class II-restricted antigenic peptides in
phagosomes. J774.1 cells were preincubated with or without 20 Wg/
ml of pepstatin A, E-64-d or CA-074 for 30 min. The cells were
then pulsed with OVA-coupled latex beads for 15 min. Various pro-
tease inhibitors were added to the culture medium throughout the
incubation. Peptide fractions were isolated from the phagosomes
and then separated on HPLC as described in Section 2. The peptide
fraction corresponding to either OVA257ÿ264 (dotted column) or
OVA323ÿ339 (hatched column) was assayed for the amount of respec-
tive peptide as described in Fig. 1. Data are shown as % of control
responses, and the results are representative of four independent ex-
periments.
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the peptides are thought to be transported into the ER by the
aid of TAP. This issue was approached via kinetic studies.
Phagosome fractions were prepared 10, 30 and 60 min after
the addition of OVA-coupled latex beads to J774.1 cells. Each
fraction was then analyzed for the content of the MHC class
I-restricted peptide, SIINFEKL, and the MHC class II-re-
stricted peptide, OVA323ÿ339 (Fig. 3A). Both MHC class I-
and class II-restricted peptides were barely detectable in the
phagosomes after 10 min of culture. It is reasonable that the
generated MHC class II-restricted peptide, OVA323ÿ339, rap-
idly associated with MHC class II molecules (I-Ad) after the
degradation of OVA in the phagosomes and, as a result, were
undetectable in the phagosomes as free peptides. This scenar-
io, however, is not applicable for the MHC class I-restricted
peptide, SIINFEKL, since this peptide is H-2Kb-restricted
and therefore unable to associate with class I molecules (H-
2Kd, H-2Dd) in the J774.1 (H-2d) phagosomes. The disap-
pearance of SIINFEKL from the phagosomes is consistent
with the transfer of the peptide from phagosome to cytosol.
Alternatively, the generated peptides were further degraded in
the phagosomes by proteases. These possibilities were exam-
ined in the following experiment.
The amount of SIINFEKL in either the phagosomes or the
cytosol fraction was determined during the chase period (Fig.
3B). Consistent with the results in Fig. 3A, the amount of
SIINFEKL in the phagosome was rapidly decreased. In the
cytosol fraction, however, the amount of SIINFEKL was
gradually increased (Fig. 3B). This inverse correlation between
the amounts of SIINFEKL in phagosome and cytosol frac-
tions strongly suggests that the MHC class I-restricted short
peptide, SIINFEKL, is in fact transferred from phagosome to
cytosol, although we cannot formally exclude the possibility
that the SINNFEKL, generated in the phagosome, was fur-
ther degraded by proteases to some extent.
4. Discussion
In this study, we describe the puri¢cation of phagosomes
using a discontinuous sucrose gradient. This simple technique
was employed to isolate pure preparations of phagosomes
from J774.1 macrophages [15]. Since sucrose gradients have
been reported to be unsatisfactory due to deleterious e¡ects of
the sucrose on the subsequent T cell assay step [14], we iso-
lated peptides from the phagosome fractions by utilizing a
reverse phase HPLC fractionation. In order to directly detect
MHC-restricted antigenic peptides in murine phagosomes, ei-
ther an antigen-speci¢c MHC-restricted T clone or T hybrid-
oma cells were utilized. The data demonstrated that an exo-
genously added OVA protein, which had been conjugated
with the latex beads, was phagocytosed by a murine macro-
phage cell line, J774.1, and degraded into at least two repre-
sentative MHC class I- and class II-restricted peptides by the
action of various cathepsins, including cathepsin B, in the
phagosomes. It has not been formally demonstrated that
both MHC class I- and class II-restricted antigenic peptides
are simultaneously generated in phagosomes. Our observation
clearly demonstrates that this is the case, at least for the OVA
antigen in murine phagosomes (Fig. 1).
It is possible that a di¡erence in the sensitivity of an assay
system could account for the di¡erence in the amount of
antigenic peptides detected in the assay, and, because of this
possibility, we attempted to minimize the di¡erence in the
sensitivities of the two assay systems. In our experiments,
nearly identical titration curves (peptide concentrations vs.
proliferative responses of CTLL-2) were obtained (data not
shown), indicating that nearly the same amount of each pep-
tide was generated in the phagosome (Fig. 1). Moreover, from
the results in Fig. 2, it seems that there is little, if any, di¡er-
ence in the usage of cathepsins between the two degradation
steps. These results also agree with the notion that two pep-
tides, with distinct MHC preferences, are generated in the
same compartment, i.e. the phagosome. We cannot, however,
exclude the possibility that there may be a di¡erence in exo-
peptidases that are involved in the ¢ne trimming of MHC
class I- or class II-restricted peptides.
A representative MHC class I (H-2Kb)-restricted antigenic
peptide, SIINFEKL, is generated in the phagosome of J774.1
cells. Although the haplotype of J774.1 cells is H-2d, we be-
lieve that they are able to generate H-2Kb-restricted antigenic
peptides, since antigen degradation was largely mediated by
cathepsins which apparently have no haplotype preferences.
In other words, it is unlikely that there are any di¡erences in
Fig. 3. Transfer of the OVA-derived, MHC class I-restricted peptide
(SIINFEKL) from the phagosome to the cytosol. A: Phagosome
fractions were prepared 10, 30 and 60 min after the addition of
OVA-coupled latex beads to J774.1 cells. The peptide fraction corre-
sponding to either OVA257ÿ264 (square symbol, solid line) or
OVA323ÿ339 (diamond symbol, dotted line) was assayed for the
amount of respective peptide as described in Fig. 1. Data are shown
as % of control responses, and the results are representative of three
independent experiments. B: Both phagosome fraction and cytosol
fraction (see Section 2) were prepared 15 and 45 min after the addi-
tion of OVA-coupled latex beads to J774.1 cells. The peptide frac-
tions corresponding to OVA257ÿ264 were collected from either phag-
osome fraction (square symbol, solid line) or cytosol fraction
(diamond symbol, dotted line) and assayed for the peptide contents
as described above. The results are representative of two independ-
ent experiments.
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the potential for degradation among phagosomes with various
haplotypes. In order to examine whether any MHC class I-
restricted antigenic peptide exits from the phagosomes to the
cytosol, our assay system is applicable because the generated
SIINFEKL is unable to bind to MHC class I molecules in
phagosomes, where the appropriate class I molecules, i.e. H-
2Kb, are not available. One can argue that the SIINFEKL
detected in the cytosol simply resulted from the destruction of
phagosomes rather than the active transfer of peptides. We
attempted to exclude this possibility by analyzing the amount
of phagosomal enzymes in the cytosol preparation. The results
of Western blotting analyses indicated that there is no evi-
dence for an increase in the levels of cathepsin D, which is
abundant in phagosomes (D. Muno, unpublished observa-
tion), in the cytosol during the chase period (data not shown).
Collectively, our results strongly suggest that the transfer of
antigenic peptides from the phagosomes to the cytosol is a
reality and, in fact, occurs (Fig. 3B).
It has already been demonstrated that solid particle-loaded
cells show a cytosolic delivery of OVA, indicating that the
phagosome to cytosol pathway for OVA is a general and
e⁄cient phenomenon in macrophages [10,11,18]. In the
present study, we demonstrate the transfer of OVA-derived
antigenic peptides from the phagosome to the cytosol. Our
observation is of interest when the role of the proteasome in
the MHC class I-restricted exogenous antigen presentation
pathway is considered. The issue of whether exogenously
added protein antigens follow the same pathway as endoge-
nous antigens, which are degraded by the proteasome in cy-
tosol, or they encounter the MHC class I molecules (either
from the plasma membrane or newly synthesized in the ER)
that enter the phagosomes (cytosolic pathway vs. non-cyto-
solic pathway; see Section 1) is unclear, at present. Our results
may permit a new model to be proposed, which is between the
two pathways. However, it is theoretically impossible for the
present experimental system to identify the precise location
for where the peptide (SIINFEKL), which is transferred to
the cytosol, encounters the appropriate MHC class I mole-
cules. A recent study demonstrated that MHC class I mole-
cules can present epitopes of the measles virus F protein in a
TAP-independent, NH4Cl-sensitive manner, suggesting that a
small fraction of MHC class I molecules enters MIIC (MHC
class II compartment) [19]. There may be a variety of path-
ways for delivering antigenic peptides to MHC class I mole-
cules. At this moment, the issue of which pathway is most
e⁄cient for MHC class I loading of antigenic peptides re-
mains unknown. Transfer of peptides from the phagosome
to the cytosol may be one of the most straightforward strat-
egies that is available for the phagocytic APC. The present
study may facilitate our attempts to develop new types of
vaccines which can deliver antigenic peptides, which can be
recognized by CD8 e¡ector cells, e.g. CTL, via phagocytosis.
In conclusion, the results herein demonstrate that murine
phagosomes are capable of simultaneously generating both
MHC class I- and class II-restricted antigenic peptides. Evi-
dence for the transfer of small antigenic peptides from the
phagosome to the cytosol was also presented. Utilizing phag-
osomes for the generation as well as the delivery of antigenic
peptides for both MHC class I and class II antigen presenta-
tion pathway represents one of the most promising ap-
proaches to vaccine delivery.
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